• sense clinically
  • think mechanistically
  • act interdisciplinarily
  • treat innovatively

Prof. Dr. rer. nat. Gerald Willlimsky

Cooperation Unit for Experimental and Translational Cancer Immunology
Institute of Immunology
Charité - Universitätsmedizin Berlin and German Cancer Research Center (DKFZ Heidelberg)

Campus Berlin-Buch
Haus 31.1
Robert-Rössle-Straße 10
13125 Berlin
Tel: +49 30 9406 1242
Fax: +49 30 450 751 3607

E-Mail: gerald.willimsky(at)charite.de


Scientific Scope

Research activities include the establishment of experimental cancer models in order to analyze cancer-host interactions, mechanisms involved in tumor rejection and to improve the efficacy of adoptive T cell therapy against various cancer. Novel therapeutic human T cell receptors to target cancer and virus antigens are identified and TCR gene therapy will be employed in the clinic.

Selected References